Can a smart pump outperform manual care for blood pressure in C-Sections?

NCT ID NCT04025918

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This trial tests an automated system that monitors blood pressure continuously and automatically delivers two medications to prevent low blood pressure during cesarean sections under spinal anesthesia. The system is compared to the standard manual approach of giving bolus doses. The study includes women aged 21-45 undergoing C-sections, and measures how often blood pressure drops below a safe threshold, as well as the occurrence of high blood pressure and nausea.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
An automated closed-loop system that monitors blood pressure and delivers phenylephrine and ephedrine via syringe pumps to prevent hypotension during C-sections.
What this could lead to
If effective, this automated system could offer a more precise and timely way to manage blood pressure during C-sections, potentially reducing risks for mothers and babies.
What could go wrong
This is a mid-stage trial, so the system may not prove more effective than manual methods. There are also risks of over- or under-treatment, which could lead to hypertension or persistent hypotension.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPOTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.